Search research articles
Contact Us
Filters
Showing results (41-50 of 309) with videos related to
Page
of 31
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
October 22, 2013
No detection of the NS5B S282T mutation in treatment-naïve genotype 1 HCV/HIV-1 coinfected patients using deep sequencing
Sandra Franco, Maria Casadellà, Marc Noguera-Julian, et al.
AIDS Reviews
|
May 10, 2002
The potential role of interleukin-2 in patients with HIV infection
Roger Paredes, Juan Carlos López Benaldo de Quirós, Eduardo Fernández-Cruz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 22, 2016
HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission
Reshmi Samuel, Marc Noguera Julian, Roger Paredes, et al.
Frontiers in Aging Neuroscience
|
August 5, 2024
Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model
Alessandra Borgognone, Maria Casadellà, María Martínez de Lagrán, et al.
Journal of Chemical Information and Modeling
|
April 16, 2016
Computational Prediction of HIV-1 Resistance to Protease Inhibitors
Ali Hosseini, Andreu Alibés, Marc Noguera-Julian, et al.
AIDS Reviews
|
February 10, 2017
The Evolving Landscape of HIV Drug Resistance Diagnostics for Expanding Testing in Resource-Limited Settings
Seth C Inzaule, Ralph L Hamers, Roger Paredes, et al.
The Journal of Antimicrobial Chemotherapy
|
June 20, 2020
HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy
Oscar Blanch-Lombarte, José R Santos, Ruth Peña, et al.
Plos One
|
June 6, 2012
Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile
José R Santos, José Moltó, Josep M Llibre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Interferon-γ-Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings
Lucía Pastor, Aina Casellas, María Rupérez, et al.
Virology Journal
|
December 6, 2013
Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy
Marc Noguera-Julian, Maria Casadellà, Christian Pou, et al.
Page
of 31
Search research articles
Search
Showing results (41-50 of 309) with videos related to
Sort By:
Page
of 31
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
October 22, 2013
No detection of the NS5B S282T mutation in treatment-naïve genotype 1 HCV/HIV-1 coinfected patients using deep sequencing
Sandra Franco, Maria Casadellà, Marc Noguera-Julian, et al.
AIDS Reviews
|
May 10, 2002
The potential role of interleukin-2 in patients with HIV infection
Roger Paredes, Juan Carlos López Benaldo de Quirós, Eduardo Fernández-Cruz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 22, 2016
HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission
Reshmi Samuel, Marc Noguera Julian, Roger Paredes, et al.
Frontiers in Aging Neuroscience
|
August 5, 2024
Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model
Alessandra Borgognone, Maria Casadellà, María Martínez de Lagrán, et al.
Journal of Chemical Information and Modeling
|
April 16, 2016
Computational Prediction of HIV-1 Resistance to Protease Inhibitors
Ali Hosseini, Andreu Alibés, Marc Noguera-Julian, et al.
AIDS Reviews
|
February 10, 2017
The Evolving Landscape of HIV Drug Resistance Diagnostics for Expanding Testing in Resource-Limited Settings
Seth C Inzaule, Ralph L Hamers, Roger Paredes, et al.
The Journal of Antimicrobial Chemotherapy
|
June 20, 2020
HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy
Oscar Blanch-Lombarte, José R Santos, Ruth Peña, et al.
Plos One
|
June 6, 2012
Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile
José R Santos, José Moltó, Josep M Llibre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Interferon-γ-Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings
Lucía Pastor, Aina Casellas, María Rupérez, et al.
Virology Journal
|
December 6, 2013
Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy
Marc Noguera-Julian, Maria Casadellà, Christian Pou, et al.
Page
of 31